Vermona Tablet 1mg (Finasteride)

Adult dose

Generally, finasteride is administered orally at a dosage of 1 mg once daily, and it can be taken regardless of meals. Generally, treatment effects are observed after using the medication for 3 months or more, and continued use is recommended to maintain treatment effects. Treatment duration and efficacy should be evaluated continuously. If the medication is discontinued, the treatment effects will disappear within 12 months.

This medication should not be administered to children or women. Females, especially those who are pregnant or may become pregnant, should avoid contact with broken pieces of this medication, as it may be absorbed through the skin and affect male fetuses. During treatment, symptoms of depression or mood changes may occur, and if such symptoms arise, medical consultation should be sought immediately. Pregnant women must not take this medication, and if taken during pregnancy or if pregnancy occurs while on this medication, the potential risks to male fetuses should be fully understood. Patients with hypersensitivity or those currently taking other 5α-reductase inhibitors, as well as individuals with lactose intolerance, should not use this medication. Patients with impaired liver function should exercise greater caution when using this medication. This medication may cause side effects related to sexual function, such as decreased libido, erectile dysfunction, and ejaculation disorders, but most symptoms will improve upon discontinuation of the medication. Prolonged use may present symptoms such as breast tenderness, breast enlargement, testicular pain, and, rarely, cases of breast cancer have been reported. This medication may affect the risk of prostate cancer; thus, regular examinations are essential for men over 55 years of age. While this medication does not have significant interactions with other drugs, it is advisable to inform healthcare providers of any concurrent medications. Animal studies during pregnancy have shown this medication can cause genital abnormalities in male fetuses, so pregnant women must not take it. It is not administered to breastfeeding women, and it is unknown whether this medication is excreted in breast milk. Safety and efficacy in elderly individuals have not been sufficiently studied, however, dosage adjustment is not necessary. This medication may lower prostate-specific antigen (PSA) levels, so caution should be exercised when interpreting test results. There are no specific treatments for overdose; store out of reach of children in a safe place. While no specific risks have been identified in carcinogenic studies, regular check-ups are recommended even during long-term use.

Serious side effects

Severe allergic reactions such as hives, angioedema (including swelling of the lips, tongue, throat, and face), rash, severe skin reactions, depression, suicidal thoughts and mood changes, possibility of breast cancer, increased risk of prostate cancer, symptoms related to liver dysfunction (jaundice - yellowing of the skin or eyes), severe neurological symptoms (severe headache, confusion, visual disturbances, paralysis)

Mild side effects

• Decreased libido
• erectile dysfunction
• ejaculation disorder
• reduced semen volume
• breast enlargement
• breast tenderness
• testicular pain
• blood clotting disorders
• orgasmic dysfunction
• muscle pain

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to keep it at a temperature between 15 to 30 degrees Celsius, avoiding extremes of heat or cold.

Appearance

Brown-yellow, film-coated tablets in an octagonal shape with convex sides on both sides

Package unit

30 tablets/box [(10 tablets/PTP × 3)]